Cargando…

Gastric neoplasms and pepsinogen phenotypes.

Detalles Bibliográficos
Autores principales:	Ellis, A., Hughes, S., McConnell, R. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1982
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011100/ https://www.ncbi.nlm.nih.gov/pubmed/7150476

Ejemplares similares

Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
por: Cha, Jae Hwang, et al.
Publicado: (2020)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis
por: Bang, Chang Seok, et al.
Publicado: (2019)

Pepsinogen and Pepsin
por: Herriott, Roger M.
Publicado: (1962)

The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case–control study in Korea
por: Cho, Jun-Hyung, et al.
Publicado: (2017)

Studies on the dynamics of pepsinogen distribution.
por: Spencer, R. P., et al.
Publicado: (1966)

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China
por: Liu, Xujuan, et al.
Publicado: (2021)

The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer
por: Juan Cai, Wei, et al.
Publicado: (2017)

Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer
por: Wang, Yaping, et al.
Publicado: (2020)

Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases
por: Jiang, Jingyi, et al.
Publicado: (2018)

Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study
por: Kwak, Min-Sun, et al.
Publicado: (2018)

Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy
por: Bang, Chang Seok, et al.
Publicado: (2019)

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020)

Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
por: Qin, Yuan, et al.
Publicado: (2023)

IMMUNOLOGICAL STUDIES ON PEPSIN AND PEPSINOGEN
por: Seastone, C. V., et al.
Publicado: (1937)

MEMBRANES OF THE HUMAN PEPSINOGEN GRANULE
por: Lillibridge, Clinton B.
Publicado: (1961)

Comparison of Gastric Cancer Risk Classifications Using Conventional and New Pepsinogen Criteria
por: Sasakabe, Tae, et al.
Publicado: (2023)

The relationship between pepsinogen C and gastric carcinogenesis: a transgene and population study
por: E., Ying, et al.
Publicado: (2023)

ENZYMIC DEPHOSPHORYLATION OF PEPSIN AND PEPSINOGEN
por: Perlmann, Gertrude E.
Publicado: (1958)

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population
por: Cai, Hao-Lei, et al.
Publicado: (2021)

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics
por: Broutet, N, et al.
Publicado: (2003)

Pepsinogens I and II in Gastric Cancer: An Immunohistochemical Study Using Monoclonal Antibodies
por: Huang, Shih Che, et al.
Publicado: (1988)

Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
por: Hattori, Yasushi, et al.
Publicado: (1995)

Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy
por: Mezmale, Linda, et al.
Publicado: (2019)

Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
por: Miftahussurur, Muhammad, et al.
Publicado: (2020)

The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
por: Shen, Hongzhang, et al.
Publicado: (2021)

Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects
por: Dondov, Ganchimeg, et al.
Publicado: (2022)

Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population
por: Zoalfaghari, Abbas, et al.
Publicado: (2014)

ISOLATION, CRYSTALLIZATION, AND PROPERTIES OF SWINE PEPSINOGEN
por: Herriott, Roger M.
Publicado: (1938)

Immunochemical Studies on the Components of the Pepsinogen System
por: Van Vunakis, Helen, et al.
Publicado: (1963)

The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China
por: Zhang, Xiao-mei, et al.
Publicado: (2014)

Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
por: Hosseini, Mosalreza, et al.
Publicado: (2013)

Low Pepsinogen I Level Predicts Multiple Gastric Epithelial Neoplasias for Endoscopic Resection
por: Park, Seon-Young, et al.
Publicado: (2014)

Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer
por: Miki, Kazumasa, et al.
Publicado: (1993)

Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis
por: Chen, Lingli, et al.
Publicado: (2021)

Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method
por: FURIHATA, Chie
Publicado: (2021)

Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer
por: Zeng, Weiwei, et al.
Publicado: (2020)

Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2022)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9g1dqc7n61g4h24v5dtvc690vd